...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium.
【24h】

Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium.

机译:镰状红细胞诱导淋巴细胞和单核细胞粘附于内皮。

获取原文
获取原文并翻译 | 示例

摘要

Infusion of epinephrine-activated human sickle erythrocytes (SS RBCs) into nude mice promotes both SS RBC and murine leukocyte adhesion to vascular endothelium in vivo. We hypothesized that interaction of epinephrine-stimulated SS RBCs with leukocytes leads to activation of leukocytes, which then adhere to endothelial cells (ECs). In exploring the underlying molecular mechanisms, we have found that coincubation in vitro of epinephrine-treated SS RBCs with human peripheral blood mononuclear cells (PBMCs) results in robust adhesion of PBMCs to ECs. Sham-treated SS RBCs had a similar but less pronounced effect, whereas neither sham- nor epinephrine-treated normal RBCs activated PBMC adhesion. PBMC activation was induced via at least 2 RBC adhesion receptors, LW and CD44. In response to SS RBCs, leukocyte CD44 and beta2 integrins mediated PBMC adhesion to ECs, a process that involved endothelial E-selectin and fibronectin. SS RBCs activated adhesion of both PBMC populations, lymphocytes and monocytes. Thus, our findings reveal a novel mechanism that may contribute to the pathogenesis of vaso-occlusion in sickle cell disease, in which SS RBCs act via LW and CD44 to stimulate leukocyte adhesion to endothelium, and suggest that RBC LW and CD44 may serve as potential targets for antiadhesive therapy designed to prevent vaso-occlusion.
机译:向裸鼠输注肾上腺素激活的人类镰状红细胞(SS RBC)可以促进SS RBC和鼠白细胞在体内对血管内皮的粘附。我们假设肾上腺素刺激的SS RBC与白细胞的相互作用导致白细胞激活,然后白细胞粘附到内皮细胞(EC)。在探索潜在的分子机制时,我们发现肾上腺素处理的SS RBC与人外周血单核细胞(PBMC)的体外共孵育导致PBMC与EC牢固结合。假处理的SS RBC具有相似但不太明显的作用,而假手术或肾上腺素处理的正常RBC均未激活PBMC粘附。 PBMC激活是通过至少2个RBC粘附受体LW和CD44诱导的。响应SS RBCs,白细胞CD44和beta2整合素介导PBMC对EC的粘附,这一过程涉及内皮E选择素和纤连蛋白。 SS RBC激活了PBMC群体,淋巴细胞和单核细胞的粘附。因此,我们的发现揭示了可能有助于镰状细胞疾病血管闭塞的发病机理的新机制,其中SS RBC通过LW和CD44刺激白细胞粘附于内皮,并提示RBC LW和CD44可能具有潜在的作用。旨在防止血管阻塞的抗粘连治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号